BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
3192 results:

  • 1. The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cells.
    Madej E; Lisek A; Brożyna AA; Cierniak A; Wronski N; Deptula M; Wardowska A; Wolnicka-Glubisz A
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):209. PubMed ID: 38656555
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Oleoylethanolamide and Palmitoylethanolamide Enhance IFNβ-Induced Apoptosis in Human Neuroblastoma SH-SY5Y cells.
    Camoglio C; Balla J; Fadda P; Dedoni S
    Molecules; 2024 Apr; 29(7):. PubMed ID: 38611871
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A basaloid carcinoma with multilocular thymic cyst mimicking a mediastinal teratoma.
    Su C; Zhu X; Wang Q; Zhang J
    J Cardiothorac Surg; 2024 Apr; 19(1):198. PubMed ID: 38600577
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cannabidiol induces erk activation and ROS production to promote autophagy and ferroptosis in glioblastoma cells.
    Kim NY; Shivanne Gowda SG; Lee SG; Sethi G; Ahn KS
    Chem Biol Interact; 2024 May; 394():110995. PubMed ID: 38583854
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. has-miR-134-5p inhibits the proliferation and migration of glioma cells by regulating the BDNF/erk signaling pathway.
    Guo Z; An P; Hong X
    Aging (Albany NY); 2024 Apr; 16(7):6510-6520. PubMed ID: 38579169
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Ergosterol promotes neurite outgrowth, inhibits amyloid-beta synthesis, and extends longevity: In vitro neuroblastoma and in vivo Caenorhabditis elegans evidence.
    Sillapachaiyaporn C; Wongwan C; Mongkolpobsin K; Nilkhet S; Isidoro C; Chuchawankul S; Tencomnao T
    Life Sci; 2024 May; 345():122606. PubMed ID: 38574884
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. miR-889-3p targeting BMPR2 promotes the development of retinoblastoma via JNK/MAPK/erk signaling.
    Gao Y; Du P
    Sci Rep; 2024 Mar; 14(1):7277. PubMed ID: 38538669
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Interleukin 3 Inhibits Glutamate-Cytotoxicity in Neuroblastoma cell Line.
    Matus V; Castro-Guarda M; Cárcamo-Fierro J; Morera FJ; Zambrano A
    Neurochem Res; 2024 May; 49(5):1373-1386. PubMed ID: 38512424
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
    Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
    Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ACA-28, an erk MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer cells.
    Takasaki T; Hamabe Y; Touchi K; Khandakar GI; Ueda T; Okada H; Sakai K; Nishio K; Tanabe G; Sugiura R
    Oxid Med Cell Longev; 2024; 2024():7683793. PubMed ID: 38500550
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.
    Yang E; Hong B; Wang Y; Wang Q; Zhao J; Cui X; Wu Y; Yang S; Su D; Liu X; Kang C
    Cancer Lett; 2024 Apr; 588():216812. PubMed ID: 38490327
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Neuroprotective Effects of Polysaccharides and Gallic Acid from
    Rangsinth P; Pattarachotanant N; Wang W; Shiu PH; Zheng C; Li R; Tencomnao T; Chuchawankul S; Prasansuklab A; Cheung TM; Li J; Leung GP
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474465
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study.
    Lu F; Wu Q; Lei J; Zhou Y; Liu Y; Zhu N; Yu Y; Lin L; Hu M
    Arch Biochem Biophys; 2024 Apr; 754():109957. PubMed ID: 38467357
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression.
    Khan F; Lin Y; Ali H; Pang L; Dunterman M; Hsu WH; Frenis K; Grant Rowe R; Wainwright DA; McCortney K; Billingham LK; Miska J; Horbinski C; Lesniak MS; Chen P
    Nat Commun; 2024 Mar; 15(1):1987. PubMed ID: 38443336
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis.
    Oskouian B; Lee JY; Asgharzadeh S; Khan R; Zhang M; Weisbrod JR; Choi YJ; Puri L; Aguilar AE; Zhao P; Saba JD
    Oncogene; 2024 Apr; 43(16):1203-1213. PubMed ID: 38413795
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A novel NIR fluorescent probe inhibits melanoma progression through apoptosis and erk/DRP1-mediated mitochondrial fission.
    He Q; Li C; Ou Y; Pan Y; Yang X; Wang J; Liao H; Xiong X; Liu L; Sun C
    Bioorg Chem; 2024 Apr; 145():107218. PubMed ID: 38377820
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PTX3 activates POSTN and promotes the progression of glioblastoma via the MAPK/erk signalling axis.
    Wang Y; Wang B; Cao W; Xu X
    Biochem Biophys Res Commun; 2024 Apr; 703():149665. PubMed ID: 38359612
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance.
    Kharouf N; Flanagan TW; Alamodi AA; Al Hmada Y; Hassan SY; Shalaby H; Santourlidis S; Hassan SL; Haikel Y; Megahed M; Brodell RT; Hassan M
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334632
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Neuroendocrine and squamous cell phenotypes of NUT carcinoma are potential diagnostic pitfalls that discriminating it from mimickers, such as small cell and squamous cell carcinoma.
    Ninomiya H; Sato Y; Inamura K; Dobashi A; Takeuchi K; Mitani H; Mun M; Nishio M; Ishikawa Y
    Diagn Pathol; 2024 Feb; 19(1):27. PubMed ID: 38326851
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Investigating the therapeutic effects of novel compounds targeting inflammatory IL-1β and IL-6 signaling pathways in spinocerebellar ataxia type 3.
    Chen IC; Chen WL; Chang KH; Lee JW; Lin TH; Lin W; Chen CM; Lee-Chen GJ
    Eur J Pharmacol; 2024 Mar; 967():176370. PubMed ID: 38320719
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 160.